CVPC is seen to change sigdcantly only in gmup 2, in whicb subjects started out with high closing volumes.
ly in the different groups. Figure 2 depicts mean changes in test values that were induced by iropmterenol in each of the four groups. The verticpt brackets around the means represent 95 pment confidence intervals, determined by multiplying the standard e n w of the mean change by the appropriate t value. Depicting the data in this manner makes its statis4icd signihuce d y a p p m t . Whenever the brpeketr overlnp the horizontal 0 percent change axis, the change brought about by isopmtemol is not stalistidy si!@cant.
However, rinm one can be 95 percent confident that the true mean change of the populntim being sampled resides within the interval the change brought about by iropnxuuml is signilkant (P < 0.05) when the brackets do not msrlap the 0 percsnt axis. Figure 2 indicat~ that FEV. inaePsed sigrdcantly in an four groups. Although the magnitude of the change issmpllerin the gmupa startingoutwith n d FEW, k i n ~1~~~4 t h e l o w w i n b i I i t~o f t h i t m~~1 t ~a a u n b f o r its uniformly signi8cant imrr~re.
CVPC is seen to change sigdcantly only in gmup 2, in whicb subjects started out with high closing volumes.
Intemtingly, C V P C iocreased in the n d subjects o f g m u p l a s w e l l a s i n t h a~p 3 s u b j e c t s , a l~ not signilkantly. Group 4 demonshated a h u g variability in C V P C changes. .. Considering the expected bmnchodilator response to isoproterenol, FEE,,.,, shows the mmt si@cant response (greatest number of standard e n u n change-6.15) with FEV, next (5.81) and Gaw/VL least signi6-m t (2.48). However, the response to 0.1 mg Th- we had measured the forced expiratory volume in one second (FEV,), the forced vital capacity (FVC) and the mid-half Bow rate (FEF,,.,,%) before and serially after the adminisintion of bronchodilators, we analyzed our data to see which of these tests best separated the Merent therapeutic regimens.
0.. values signi6cantly increased after
Twenty adult patients with reversible airway disease were studied. Each patient was randomly given the following 6ve drug regimens in a double-blind manner: fenoterol400, 200, and 100 fig, isopmterenol 150 pg and placebo. Medications were administered via freon propellant in metered dose inhalers. The results were expressed as the time-weighted mean percent improvement over the four hours following drug administration. The drug regimens could be ranked as follows (Fig   1 ) : fenoteml 400 ,~g > , fenoteml 200 pg>, fenoteml 100 pg>, isopmterenol 150 pg>, placebo. When the percent mean impmvement in the various tests was calculated, the greatest improvement was seen in the G a w p~, followed by the FEE ,,.,, %, FEV, and FVC.
However, these percent changes do not take into amount the inherent variability of the tests. This variability can be compensated for in the statistical procedure lolown as the analysis of variance. It is based on the principle that in the evaluation of a response to a treatment, some of the variance in tests is due to the treatment while some is due to other factors such as the measurement itself, and spontaneous variations not due to the treaiment. The ratio of the variance athihutable to the drugs divided by the variance not attributable to the drugs is lmown as the F value. The higher the F value, the more sigdcant the results. The order of the F values (Fig 1) is in marked contrast to that when the percent increase is considered.
The FEV, has the highest F value followed by the Raw and the FVC. The Gaw/VL and the FEF,,.,,% which have the highest percentage of mean improvement have relatively lower F values.
Higher F values should be associated with more statistically s i d c a n t conclusions. Using five drug regimens, there are ten cornpadsons to make (Table 1 ) . Use of the FEV, allows seven statistically s i d c a n t conclusionz to be made while no more than six conclusions can be made 
